Experience

CHEMIUM

• Belgium
• Research
• 1 - 100 Employee

• R&D manager Process chemistry

  • Jun 2016 - Present



GSK

• United Kingdom
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Scientist

  • Apr 2016 - Jun 2016

• Production Manager Logistic Formulation & Filling

  • Jun 2014 - Mar 2016



Job Placement Ltd

• 1 - 100 Employee

• Novasep-Henogen

  • Dec 2013 - Feb 2014

  Management of Non-conformity. Management of Non-conformity.



3-Month training

• Nivelles

• Cequal

  • Aug 2013 - Nov 2013

  Management Systems (ISO)-Tools: AMDEC; Statistics (Fisher-Student; ANOVA..); Quality & performance indicators, Kepner-Tregoe methodology; Ishikawa diagram; Pareto; 5S methodology... Management Systems (ISO)-Tools: AMDEC; Statistics (Fisher-Student; ANOVA..); Quality & performance indicators, Kepner-Tregoe methodology; Ishikawa diagram; Pareto; 5S methodology...



Albemarle Corporation

• United States
• Chemical Manufacturing
• 700 & Above Employee

• R&D Manager

  • Jan 2007 - Mar 2013

  Mission: To develop chemical processes for the preparation of chemical entities and customer deliveries. Main Responsabilities: * Management of a Fine Chemical R&D team. * Project Management: - Business prospection. - Preparation of technical packages - Raw material sourcing. - Process development of chemical entities. - Preparation of safety reports. - Production at kilo lab scale. - Cost evaluation. - Transfer to US plants. - Interface with Customer. * Laboratory safety. Key Accomplishments: * Process development of many chemical entities: Pharma-Agro-Photovoltaic candidates-Compounds from biomasse-component for perfumes. * Customer deliveries. * 5 Patents.



Eli Lilly and Company

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Research scientist

  • Feb 2001 - Dec 2006

  Mission: Process development and delivery of New Chemical Entities for Tox studies. Main responsabilities: * Process development of API from pre-clinical studies to Phase IIa. * Supervision of scientists. * Transfer of chemical processes to Pilot plant for GMP manufacturing. * Development of analytical methods. * Coordination of chemical intermediate sourcing. * Oral and writting communications. Key Accomplishments: * Process development of Edivoxetine from stage III to Phase IIa. * Delivery of 7 API for preclinical studies. * 31 chemical reactions scaled up in kilo lab area (150 g-1.5 kg). * Delivery of 2 Phase I candidates and 1 Phase IIa candidate. * 3 Articles.



Université catholique de Louvain

• Belgium
• Research Services
• 700 & Above Employee

• Research associate

  • Feb 1999 - Feb 2001

  * Development of regio and stereoselective cyclopropanation of dienyl boronate- * Preparation of Ambruticine moieties. * Development of regio and stereoselective cyclopropanation of dienyl boronate- * Preparation of Ambruticine moieties.